What complications can occur with norovirus infection, particularly in elderly, very young, immunocompromised, or postoperative patients (e.g., after surgery with cefazolin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norovirus Complications

Norovirus infection, while typically self-limited in healthy adults, can cause severe and life-threatening complications in elderly, immunocompromised, and postoperative patients, including acute renal failure, cardiac arrhythmias, prolonged viral shedding lasting months to years, and mortality rates up to 25% in allogeneic stem cell transplant recipients. 1, 2

High-Risk Populations and Specific Complications

Immunocompromised Patients

Immunocompromised individuals face the most severe complications, including:

  • Chronic diarrhea lasting months to years rather than the typical 1-3 day course seen in healthy individuals 2, 3
  • Mortality rates up to 25% have been documented specifically in allogeneic stem cell transplant patients 1, 4
  • Acute agranulocytosis has been reported in pediatric kidney transplant recipients, presenting as febrile neutropenia that resolves with improvement of gastrointestinal illness 5
  • Prolonged viral shedding continuing for extended periods, increasing transmission risk 1, 4
  • Signs of acute graft organ rejection in renal transplant patients 6

Elderly Patients

Older adults experience disproportionately severe outcomes:

  • Norovirus-associated deaths occur particularly in long-term care facility outbreaks 2, 3
  • Prolonged illness duration of 4-6 days compared to 1-3 days in healthy adults 2, 4, 3
  • Age >65 years is an independent risk factor for diarrhea lasting >2 days (OR 11.6,95% CI 1.89-224) 6
  • Severe dehydration requiring hospitalization and intravenous fluid resuscitation 3, 7

Patients with Cardiovascular Disease

Cardiovascular complications represent a critical but underrecognized risk:

  • Cardiovascular disease is a major risk factor for potassium decrease >20% (OR 17.1,95% CI 2.17-403) 6
  • Cardiac arrhythmias have been documented during norovirus outbreaks in hospitalized patients 6
  • Electrolyte disturbances including severe hypokalemia requiring monitoring and replacement 6

Renal Transplant Recipients

This population faces multiple severe complications:

  • Renal transplant status is an independent risk factor for potassium decrease >20% (OR 13.0,95% CI 1.63-281) 6
  • Acute renal failure has been observed during norovirus infection 6
  • Immunosuppressive therapy increases risk of creatinine elevation >10% (OR 5.7,95% CI 1.78-20.1) 6

Metabolic and Laboratory Complications

Beyond gastrointestinal symptoms, norovirus causes systemic metabolic derangements:

  • Decreased potassium levels requiring aggressive monitoring and replacement, particularly in patients with cardiovascular disease or renal transplants 6
  • Increased C-reactive protein and creatine phosphokinase levels indicating systemic inflammation 6
  • Acute dehydration as the most common serious complication requiring hospitalization 3, 7

Clinical Course in High-Risk Groups

The typical self-limited course does not apply to vulnerable populations:

  • While immunocompetent individuals experience symptoms for 12-72 hours, young children, elderly, and hospitalized patients frequently have prolonged courses of 4-6 days 2, 4, 3
  • Vomiting or diarrhea persisting >1 week is atypical and requires immediate evaluation for alternative diagnoses 2
  • Peak viral shedding occurs 2-5 days after infection with approximately 100 billion viral copies per gram of feces, and shedding can continue for an average of 4 weeks 4, 3

Critical Management Considerations for High-Risk Patients

Patients at risk should be hospitalized early and monitored frequently for the following:

  • Electrolyte abnormalities, particularly potassium levels in patients with cardiovascular disease or renal transplants 6
  • Renal function through serial creatinine measurements, especially in immunosuppressed patients 6
  • Cardiac rhythm monitoring in patients with cardiovascular disease due to arrhythmia risk 6
  • Volume status with aggressive oral or intravenous rehydration as needed 3

Postoperative Context

While the evidence does not specifically address norovirus complications in patients receiving cefazolin or other postoperative antibiotics, the general principles for immunocompromised and hospitalized patients apply. Postoperative patients may be at increased risk due to:

  • Temporary immunosuppression from surgical stress 8
  • Hospitalization in semi-closed environments where norovirus outbreaks frequently occur 8, 9
  • Potential for severe dehydration complicating postoperative recovery 3

Strict infection control measures should be implemented immediately when norovirus is suspected in any high-risk patient to prevent nosocomial transmission 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norovirus Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norovirus Gastroenteritis – Evidence‑Based Clinical and Public‑Health Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Norovirus Incubation Period and Clinical Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient.

Transplant infectious disease : an official journal of the Transplantation Society, 2012

Research

Risk groups for clinical complications of norovirus infections: an outbreak investigation.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006

Research

Norovirus: noxious in nursing facilities-almost unavoidable.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012

Research

Managing outbreaks of norovirus in an NHS hospital.

British journal of nursing (Mark Allen Publishing), 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.